ABSTRACT--We investigated the potency of two oil adjuvants, Montanidae ISA 763A (763A) and a squalene emulsion (Squalene), to enhance the response of ayu Plecoglossus altivelis to a forma lin-killed bacterin (FKB) made from the coidwater disease etiologic agent, Flavobacterium psychrophilum.
Flavobacterium psychrophilum was originally iso lated in 1948 from coho salmon Oncorhynchus kisutch in the USA, and is well known as the causative agent of bacterial coldwater disease (Holt et al., 1993) and rain bow trout fry syndrome (RTFS, Lorenzen et al, 1997) . In Japan this pathogen was first isolated from ayu Plecoglossus altivelis in 1987, and has spread throughout most prefectures (Wakabayashi et al, 1994) . Recently, bacterial coldwater disease has caused high mortality of ayu in farms and natural waters and is con sidered to be one of the most serious fish diseases in Japan.
Therapeutic treatments are not applicable in natural waters and therefore development of vaccines is needed.
Although an effective vaccine using an inacti vated strain of F. psychrophilum has been reported for the prevention of bacterial coidwater disease in trout (Obach and Baudin Laurencin, 1991) , no vaccine for ayu is currently available.
Commercial vaccines to protect fish against bacte rial pathogens typically consist of killed cells, extracellular fractions, or cell culture supernatants (Ellis, 1997) . In a preliminary experiment, we attempted to develop a vaccine using a formalin killed bacterin (FKB) of F.
psychrophilum, but encountered low efficacy. It is well recognized that development of a successful vaccination strategy depends on the presence of protective antigens, stimulation of the immune system and appropriate deliv ery to the host. Adjuvants have become important tools for increasing vaccine potency (Anderson, 1997) , and the use of oil adjuvants combined with antigens has resulted in a substantial reduction in the use of antibac terial drugs in Norway (Markestad and Grave, 1997 Statistical analysis Significant differences between treatments in levels of mortality after challenge were detected by Fisher's exact probability test. The relative percentage survival was calculated when a significant difference was detected between mortalities in control and vaccinated groups. Data for the agglutination antibody titer were first subjected to the F test in order to detect significant differences between variances.
When the difference in variances was significant, the data were subjected to the Cochran-Cox test in order to detect significant differ ences between means. The rest of the data were sub jected to the Student's unpaired t test in order to detect significant differences between means. Significance level for all statistical analyses was P<0.05.
Results
The lethal dose (LD50) of the F. psychrophilum strain PH-9304 was 104.3 CFU/fish (Table 1) . Fish began to die on the 3rd day post injection in the group inoculated with the highest dose. Disease signs and mortalities continued for 10 days in all injected groups.
In the challenge with a high dose of the pathogen, fish began to die on the 5th day post challenge and con tinued to die until the 10th day post challenge in the vac cinated groups. Cumulative mortality was 24% in the Squalene-vaccinated group, 30% in the 763A-vaccinated group and 45% in the FKB-vaccinated group. In contrast, fish in control group continued to die until the 11th day post challenge and the cumulative mortality was 75%. In the group challenged with a low dose, mortalities began on the 5th day post challenge and con tinued until the 9th day post challenge. The mortalities of groups administered the adjuvanted vaccines were Table1.
Mortality of ayu injected intramuscularly with F. psychrophilum strain PH-9304 Table 2 . Relative percentage survival (RPS) of vaccinated ayu after challenge with F.psychrophilum Table 3 . Agglutinating antibody titers in sera of vaccinated and non-vaccinated ayu significantly lower than those administered the FKB vac cine alone, while the FKB vaccine showed significantly higher potency than the control (sterile distilled water). There was no significant difference between the two adjuvanted vaccines (Table 2) . The agglutinating antibody titers of sera from fish in the vaccinated, non-vaccinated and pre-immunized groups are shown in Table 3 . The highest antibody titers were found in the Squalene vaccinated group and the 763A vaccinated group. The FKB vaccinated fish showed higher antibody titers than control fish which showed antibody titers similar to those of pre-immune fish. The antibody titers of fish vaccinated with the adjuvanted vaccines were significantly higher than those of fish in the FKB vaccinated group or control group. However, there was no significant difference in t iter between the groups vaccinated with the 763A-and the Squalene vaccine.
Discussion
Ayu vaccinated with the 763A vaccine showed sig nificantly (P<0.05) greater protection against coldwater disease than ayu vaccinated with the FKB vaccine or distilled water. This result agrees with previous studies on the use of adjuvants in vaccines for other fish species. Krantz et al. (1963) first reported that formalin killed Aeromonas salmonicida with an adjuvant (one part arlacel to nine parts klearol mineral oil) increased anti body titer in brown trout. Adams et al. (1988) reported that an adjuvant combined with formalin-killed cells of A. salmonicida gave better protection in rainbow trout against furunculosis compared to the formalin-killed cells alone. Similarly, Holt (1987) reported the high potency of an adjuvanted vaccine for coldwater disease in coho salmon. We have conducted several challenge tests to further investigate the efficacy of the 763A vaccine and found similar results to those shown in Table 2 . How ever, 763A adjuvant was retained in ayu for more than 4 wk but less than 8 wk (data not shown).
For the development of commercial ayu vaccines, it will be important to find adjuvants with shorter retention times. Screening of adjuvants with shorter retention periods is under investigation in our laboratory. Souza and Playfair (1995) reported the effective ness of an oil-in-water emulsion squalene vaccine for humans against blood-stage malaria, and Estuningsih et al. (1997) reported that squalene Montanidae 80,MF59 -100 with antigen induced moderate to high antibody titer in cattle. Allison (1999) reported that squalene emul sions are efficient adjuvants, eliciting both humoral and cellular immune responses in primates. In the present study, the vaccine containing Squalene as an adjuvant was very effective in ayu. Fish vaccinated with the Squalene-adjuvanted FKB showed significantly (P<0.05) greater protection against coldwater disease in ayu than those vaccinated with the FKB vaccine or distilled water. This result suggests that squalene is a good candidate for inclusion in adjuvanted vaccines for fish as well as those for mammals.
Additional studies have confirmed the efficacy of the Squalene vaccine as shown in Table 2 , although, as the 763A vaccine, the retention period of Squalene in ayu was between 4 and 8 wk (data not shown).
In the present study two adjuvanted vaccines pro duced significantly higher antibody titers in ayu than the FKB vaccine without adjuvant.
These findings are con sistent with previous reports in coho salmon (Paterson and Fryer, 1974) and rainbow trout (Cossarini-Dunier, 1985) . It is generally accepted that the adjuvant forms a depot that releases the antigen slowly into the tissue or blood, enhancing and prolonging the humoral immune response (Anderson, 1992) . We also found good cor relation between protection and antibody titer, as previ ously reported for carp vaccinated with A. hydrophila (Karunasagar et al., 1997) . Midtlyng et al. (1996) also observed that antibody could play a very important role in protection of Atlantic salmon against furunculosis. In the present study, similar phenomena may have oc curred in adjuvant-vaccinated ayu, which showed higher antibody titers than those of FKB-vaccinated ayu. Brown et al. (1997) showed that F. psychrophilum was vertically transmitted in coho salmon, and Kumagai et al. (1998) reported that povidone-iodine treatment was ineffective to eliminate F. psychrophilum from salmonid eggs. These reports suggest that the vertical transmis sion of the bacterium is possible in ayu. Ayu brood stock are sometimes seriously affected by coldwater disease.
Therefore, it is essential to keep broodstock pathogen-free to prevent the vertical transmission.
In the present study, we found that many more ayu were free from pathogen in the groups treated with adjuvanted vaccine than the group treated with non-adjuvanted vac cine on the 5th day post challenge with live pathogen (data not shown). This result indicates that injection vaccination with the Squalene-or the 763A vaccine can be applied to protect ayu broodstock from coldwater dis ease. 
